Endometrial Cancer Trial, Recruiting NCT04588402 Sponsor: International Agency for Research on Cancer Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT04588402
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women between 18 and 22 years old who live in Sikkim and are married
  • Women who are pregnant (pregnancy does not prevent joining this trial)
  • Sample collection should not take place while a woman is actively menstruating

Who may not be able to join:

  • Women who do not provide written consent to participate
  • Women who are unable to cooperate with the cervical cell sample collection or answer questions due to a serious physical or mental health condition
  • Women who have had their uterus surgically removed (a hysterectomy)
  • Women who have already received a vaccine as part of a research project

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yogesh Verma, MD, Sikkim Manipal Inst., Sikkim, India

Phone: +33 472 738 167

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
International Agency for Research on Cancer
Registry
ClinicalTrials.gov
Start date
1 October 2020
Est. completion
30 October 2026

Where this trial is recruiting

🇮🇳 India

Primary endpoints

The reduction in the point prevalence of genotype-specific HPV infection in women within 7 years of initiation of HPV vaccination compared to that at baseline; The difference in the point prevalence of chlamydia trachomatis infection in women within 7 years of initiation of HPV vaccination compared to that at baseline

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov